Last reviewed · How we verify
Compound-X
At a glance
| Generic name | Compound-X |
|---|---|
| Sponsor | IlDong Pharmaceutical Co Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Compound-X CI brief — competitive landscape report
- Compound-X updates RSS · CI watch RSS
- IlDong Pharmaceutical Co Ltd portfolio CI